← Back to headlines
BioMarin and Ascendis Health Resolve Global Patent Disputes Through Settlement
Pharmaceutical companies BioMarin and Ascendis Health have reached a mutual agreement to end longstanding international patent conflicts, clearing legal hurdles for both firms.
31 Aug, 12:06 — 31 Aug, 12:06
Sources
Showing 1 of 1 sources
Related Stories
Japan and U.S. Advance $550 Billion Investment Pact Focused on AI and Chips
58m ago
Anthropic Delays AI Startup IPO to Mid-October Amid Credit Facility Deal
2h ago
Trade Negotiations Stall as U.S. Halts Antitrust Cooperation With Canada
2h ago
Corporate Executives Across Various Sectors Sell Company Stock
2h ago